Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.44% inched 0.46% higher to $172.66 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.08% falling 0.47% to 4,401.46 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.15% falling 0.24% to 35,058.52. This was the stock's sixth consecutive day of gains. Johnson & Johnson closed $0.99 short of its 52-week high ($173.65), which the company reached on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +1.14% fell 3.05% to $369.01, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.06% rose 0.79% to $77.85, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.63% rose 0.69% to $42.10. Trading volume (6.9 M) eclipsed its 50-day average volume of 6.4 M.